Alyeska Investment Group, L.P. - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 51 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2018$1,195,000
-24.9%
5,000,0000.0%0.01%
-15.4%
Q1 2018$1,592,000
-37.3%
5,000,0000.0%0.01%
-35.0%
Q4 2017$2,540,000
-76.8%
5,000,000
-57.5%
0.02%
-75.6%
Q3 2017$10,971,000
+38.2%
11,756,372
-16.3%
0.08%
+24.2%
Q2 2017$7,939,000
-11.1%
14,037,593
-0.9%
0.07%
-8.3%
Q1 2017$8,932,000
-19.7%
14,159,942
-2.9%
0.07%
-21.7%
Q4 2016$11,124,000
+1679.8%
14,586,592
+5200.6%
0.09%
+1214.3%
Q3 2015$625,000275,1880.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,998,941$5,839,0002.81%
Knoll Capital Management, LLC 3,400,816$4,965,0001.95%
Third Security, LLC 12,300,768$17,960,0000.82%
MSD Partners, L.P. 3,583,500$5,232,0000.12%
Genesis Wealth Advisors, LLC 35,000$78,750,0000.06%
THOMPSON DAVIS & CO., INC. 20,000$29,0000.03%
TFS CAPITAL LLC 157,800$230,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$35,0000.01%
WEDBUSH SECURITIES INC 12,000$18,0000.00%
REGIONS FINANCIAL CORP 100,000$146,0000.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders